PASADENA, Calif. (AP) — PASADENA, Calif. (AP) — Xencor Inc. (XNCR) on Tuesday reported a loss of $19.1 million in its fourth quarter.

The Pasadena, California-based company said it had a loss of 31 cents per share.

The results missed Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for earnings of 36 cents per share.

The biotech developing antibodies for severe autoimmune/allergic diseases and cancer posted revenue of $44.7 million in the period, also missing Street forecasts. Three analysts surveyed by Zacks expected $140.8 million.

For the year, the company reported a loss of $126.1 million, or $2.08 per share. Revenue was reported as $168.3 million.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on XNCR at https://www.zacks.com/ap/XNCR

For copyright information, check with the distributor of this item, STATS Perform dba Automated Insights. , source Associated Press News